Compare HDB & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HDB | MCK |
|---|---|---|
| Founded | 1994 | 1833 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.1B | 91.0B |
| IPO Year | 2002 | 1995 |
| Metric | HDB | MCK |
|---|---|---|
| Price | $24.72 | $778.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $952.92 |
| AVG Volume (30 Days) | ★ 9.5M | 869.7K |
| Earning Date | 04-18-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.53% | 0.40% |
| EPS Growth | N/A | ★ 49.22 |
| EPS | N/A | ★ 38.38 |
| Revenue | N/A | ★ $112,084,000,000.00 |
| Revenue This Year | N/A | $14.94 |
| Revenue Next Year | $14.82 | $8.21 |
| P/E Ratio | ★ $18.92 | $20.46 |
| Revenue Growth | N/A | ★ 3.11 |
| 52 Week Low | $22.91 | $637.00 |
| 52 Week High | $79.62 | $999.00 |
| Indicator | HDB | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 51.57 |
| Support Level | $23.83 | $727.64 |
| Resistance Level | $25.30 | $779.31 |
| Average True Range (ATR) | 0.48 | 16.19 |
| MACD | 0.24 | 5.54 |
| Stochastic Oscillator | 70.93 | 70.38 |
HDFC Bank Ltd is an Indian bank. It operates in the following segments: Treasury, Retail banking, Wholesale banking, and Other banking business. The maximum revenue for the company is generated from its Retail banking segment, which serves retail customers through its branch network and other channels. This segment raises customer deposits and provides loans and other services to customers using different product groups. Its other operations include providing wholesale banking services to corporates, government entities, and other enterprises, generating income from its treasury operations, and performing para-banking activities such as offering credit cards, debit cards, etc. Geographically, the company generates a majority of its revenue from its operations in India.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.